ASH 2022: High-Dose Methotrexate Does Not Lower Risk for CNS Relapse in Children, Young Adults With ALL, LBL
The treatment may improve bone marrow relapse rate in some subgroups
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Brain Cancer Center of Excellence
Visit our Brain Cancer Center of Excellence for additional, in-depth coverage.